SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SAFESKIN -- Ignore unavailable to you. Want to Upgrade?

To: Ron Kline who wrote (385)10/29/1998 9:06:00 AM
From: agent99  Read Replies (3) | Respond to of 828
 
SFSK is trading down preopening due to a downgrade this morning by the the analyst at Salomon who now has a 12 month price target of $27. Would love to see the report if someone could post it. Stock just traded at 21.

Safeskin Corp. Cut to 'Neutral' at Salomon Smith Barney.

Bloomberg News
October 29, 1998, 5:30 a.m. PT

Princeton, New Jersey, Oct. 29 (Bloomberg Data) -- Safeskin Corp. (SFSK US) was downgraded to ''neutral'' from ''buy'' by analyst Melissa Wilmoth at Salomon Smith Barney. The 12-month target price is $27.00 per share.



To: Ron Kline who wrote (385)10/29/1998 6:34:00 PM
From: Apple12  Respond to of 828
 
I agree its a game. Well at least we got some support today from the other analysts. 1 gave us a buy with a 12 month target back to $50. Good luck and keep in touch.



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News